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Abstract 
With amyloid diseases poised to become a major health burden in countries with 
ageing populations, diagnostic molecules that aid the detection of amyloid in vitro 
and in vivo are of considerable clinical value. Understanding how such ligands 
recognize their amyloid targets would help to design diagnostics that target specific 
amyloid types associated with a particular disease, but methods to provide 
comprehensive information are underdeveloped. Here solid-state NMR is used to 
determine the molecular orientation of the amyloid diagnostic 1-fluoro-2,5-bis[(E)-3-
carboxy-4-hydroxystyryl]-benzene (FSB) when bound to fibrils of the $O]KHLPHU¶V
amyloid-E polypeptide aligned on a planar substrate. The 19F NMR spectrum of the 
aligned complex reveals that FSB is oriented approximately parallel with the fibril 
long axis and bridges four hydrogen-bonded E-sheets. In addition to providing atomic 
details to aid the design of amyloid-specific diagnostics, this approach will also 
illuminate the molecular mechanisms of accessory molecules in amyloid disease.   
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The sporadic deposition of insoluble, fibrillar protein-rich deposits within extracellular 
spaces is associated with several disorders afflicting humans in later life,1 the 
archetype being the amyloid-E (AE SRO\SHSWLGHV DVVRFLDWHG ZLWK $O]KHLPHU¶V
disease.2 The atomic details of how proteins self-assemble into amyloid fibrils -  
central to our mechanistic understanding of amyloid disease - have been revealed by 
advances in solid-state NMR (SSNMR)3-8 and cryo-electron microscopy methods9 
and complete atomic-level models of fibril architectures are now available.5, 10-11 To 
gain a broader understanding of amyloid disorders it is also important to elucidate 
how biological molecules known to promote fibril formation in vivo 12 and diagnostic 
molecules that detect the formation of amyloid in vivo and in vitro 13 recognize and 
bind to the generic amyloid cross-E motif. Structural insights into ligand binding 
would cast light on their role in the assembly mechanism and open the door to the 
tailored design of diagnostics that recognize amyloid from different protein 
precursors.  Atomic details of amyloid-ligand complexes are scant, however, owing 
to a shortage of high-resolution methods that can determine both the interaction sites 
and the orientation of ligands within fibrils.  Here we demonstrate an approach that 
exploits SSNMR of macroscopically-aligned fibrils of the 40-amino acid amyloid-E 
peptide (AE40) to determine the orientation of a bound diagnostic ligand. When 
combined with other experimentally-determined restraints, a comprehensive picture 
of the amyloid-ligand complex is revealed. 
Magic-angle spinning (MAS) SSNMR has provided the few available atomic 
details of amyloid-ligand complexes, such as the binding sites for heparin within 
AE40
 
fibrils14-15 and the amyloid dye Congo red within the functional prion HET-
s(218-289) amyloid.16 Perturbations of protein chemical shifts or dipolar-driven 
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polarization transfer between protein and ligand nuclear spins identify the amino acid 
residues flanking the ligand binding site(s).14, 16-17 but do not report on how the ligand 
aligns on the fibril surface.  Ligands may, for example, insert laterally between 
hydrogen-bonded E-strands, or longitudinally stabilized by side-chain ladders running 
parallel with the fibril axis (Figure S1, supporting information).    
 
Figure 1. Binding of FSB to [U-15N,13C]AE40 fibrils prepared homogeneously in the 
3Q morphology18-19 (a) Chemical structure of FSB. (b) Fluorescence emission 
spectrum (with excitation at 360 nm) of FSB in the absence and presence of AE40 
fibrils. (c) Concentration-dependence of FSB binding to fibrils (45 PM AE40 monomer 
equivalent). (d) Detection of close contacts between AE40 residues in [U-
15N,13C]AE40 fibrils and 19F of bound FSB using 13C{19F}REDOR SSNMR.  Top: 
region of a full-echo spectrum (black) obtained without 19F dephasing and a 
difference spectrum (', with 10-fold vertical expansion) after subtracting a dephased-
echo spectrum obtained with a train of 21 S pulses at the 19F frequency.  The full 
REDOR spectra are shown in Figure S3. Bottom: a 13C-13C spectrum of fibrils 
(obtained with 20 ms DARR mixing), with labelled peaks assigned as described 
previously.4, 15    
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:H UHDVRQHG WKDW D OLJDQG¶V binding orientation can be determined by NMR if the 
insoluble fibrils are aligned in the applied magnetic field.  AE40 fibrils have been 
partially aligned on planar substrates enabling SSNMR measurements of nuclear 
spin tensor orientations to refine pre-defined structural models.20 The high length-to-
width ratio of amyloid fibrils favors an anisotropic distribution of orientations in which 
most fibrils lie in the substrate plane.  
We tested the theory with the fluorescent amyloid diagnostic ligand 1-fluoro-2,5-
bis[(E)-3-carboxy-4-hydroxystyryl]-benzene21-22 (FSB, Figure 1a), which undergoes a 
large fluorescence enhancement in the presence of amyloid (Figure 1b). The large 
chemical shift anisotropy (CSA) of 19F is a sensitive intrinsic reporter on the 
molecular orientation of the planar conjugated ring system. Fibrils of uniformly 15N, 
13C-labeled AE40 bound FSB with an association constant Ka of 9.8 PM and 
AE40:FSB stoichiometry of approximately 2:1 at saturation (Figure 1c and Figure S2, 
a-c). The insoluble fibrils retained strong fluorescence when viewed under a UV lamp 
(Figure S2d), confirming co-localization of the fibrils and FSB. An intimate contact 
between FSB and the fibrils was confirmed by a 13C-observed {19F-dephased} 
rotational-echo double-resonance (REDOR) MAS SSNMR experiment on a 1:2 
complex of FSB with [U-15N,13C]AE40 fibrils (Figure 1d, top).   The most prominent 
peaks in the 13C{19F}REDOR difference spectrum, which correspond to 13C sites 
estimated to be < 6 Å from 19F of FSB (Figure 1d and Figure S2d), are assigned with 
reference to a 2D 13C-13C NMR spectrum (Figure 1d). These sites include Val (CD 
and CJ/J¶, Ile (CE¶G), Leu (CG/G¶ and Ala (CD) (Figure 1d, bottom). That selective 
dephasing is observed in the difference spectrum suggests that FSB occupies 
specific sites rather than decorating the fibril surface non-specifically.   
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Figure 2. NMR detects the macroscopic alignment of [U-15N,13C]AE40 fibrils on glass 
cover slips. B0 is normal to the plane of the glass surface. (a) When deposited on the 
planar surface, fibrils (green cartoon) may assume preferred orientations in which 
the backbone N-H ± O=C hydrogen bonds (approximately parallel with the fibril long 
axis) are oriented at a mean angle T +/- angle \ in a Gaussian distribution about the 
mean. For unoriented fibrils, angle T takes all values from 0-360°. (b) 1H-15N PISEMA 
spectrum of unoriented hydrated fibrils (black) overlaid with a simulated spectrum 
(red) for typical backbone 15N chemical shift tensor elements of G11 = 223 ppm, G22 = 
75 ppm and G33 = 55 ppm. (c) PISEMA spectrum of fibrils deposited on cover slips 
overlaid with a simulated spectrum (red) for angles T = 0 +/- 5°.   
The FSB-[U-15N,13C]AE40 fibril complex was next deposited on a planar 
substrate of glass cover slips and 15N NMR was used to confirm the fibril alignment. 
The cover slips were stacked and inserted into an NMR probe-head with a fixed 
angle, rectangular-wound coil with the applied magnetic field B0 normal to the plane 
of the substrate.  Randomly-dispersed fibrils were also prepared (in a non-spinning 
MAS rotor) for comparison.  The 15N line shape reflects the degree of fibril alignment, 
represented by a distribution of fibril orientations on the substrate (or in the MAS 
rotor) about a mean tilt angle Trelative to B0 (Figure 2a). The fibrils were visualized 
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by 1H-15N PISEMA NMR, which correlates the anisotropic 15N chemical shift of the 
peptide backbone amides with the amide N-H dipolar coupling of the same amino 
acid residue for each molecular orientation. The spectrum of randomly-dispersed 
fibrils correlates a broad range of chemical shifts and dipolar couplings expected for 
a powder-like distribution of crystallites (Figure 2b). The spectrum of fibrils on the 
cover slips is much narrower in both dimensions (Figure 2c) and consistent with a 
restricted ensemble of fibrils distributed about a tilt angle T of 85° +/- 5° (simulated 
spectra for fibrils oriented parallel and perpendicular to B0 are shown in Figure S4).   
 
Figure 3.  Simulations of 19F NMR spectra of FSB bound to aligned fibrils.  (a) The 
19F NMR line shape is dependent on the orientations of the principal axes of the 19F 
chemical shift tensor,ߜመଵଵ, ߜመଶଶ and ߜመଷଷǡ relative to the fibril axis (approximately parallel 
with the backbone N-H bonds), defined by angles DCF and ECF. The directions of ߜመଵଵ, ߜመଶଶ and ߜመଷଷ in the FSB molecular frame (calculated and measured) give the 
orientation of FSB relative to the fibril axis. (b) Simulated proton-coupled 19F NMR 
spectra in which each of the principal axes is aligned along the fibril axis.  
We developed a theoretical framework to analyse the 19F NMR line shape and 
determine the orientation of FSB relative to the fibril axis in the aligned FSB-[U-
15N,13C]AE40 complex (Figure 3, Supporting Information sections 1.6-1.8 and 
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Figures S5-S8). 19F NMR spectra were next obtained for the FSB-[U-15N,13C]AE40 
complex. Proton-decoupled 19F spectra could be obtained on unoriented fibrils in a 
non-spinning MAS probe, but for the aligned fibrils 19F-observation with proton-
decoupling was not possible using the flat-coil probe.  The proton-decoupled 
spectrum from FSB bound to unoriented fibrils is typical of an axially asymmetric 19F 
CSA tensor (Figure 3a, top), and the principal values measured by line fitting to the 
spectrum (Table S1) were used in the subsequent simulations.  The proton-coupled 
spectrum of the same sample was compared with a simulated spectrum based on 
the measured principal values and the predicted dipolar couplings from the optimised 
geometry, with no line fitting (Figure 3a, middle).  The good agreement between the 
experimental and simulated line shapes indicates that the predicted couplings and 
geometry of the dipolar vectors are represented accurately in the calculations.  
Finally, the proton-coupled 19F NMR spectrum of the oriented FSB-[U-15N,13C]AE40 
complex was obtained (Figure 3a, bottom). The spectrum is narrower than that of the 
unaligned samples and so consistent with restricted orientations of the FSB ligand.   
Comparison of the spectrum with simulated spectra for combinations of [DCF, 
ECF] values from 0 ± 180° yielded a two-dimensional array of F2 values representing 
the variance of the experimental and simulated spectra (Figure S8). The closest 
agreement is found for [-DCF ] and either [ECF ] or [ECF 
130°]; a representative simulated spectrum (for DCF = 0°, ECF = 115°) is overlaid with 
the experimental spectrum in Figure 4a (bottom; red).This range of angles is 
consistent with FSB molecules having an approximately longitudinal orientation 
relative to the fibril axis (Figure S1) and spanning 4 hydrogen  
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Figure 4. Orientation of FSB when bound to macroscopically aligned [U-15N,13C]AE40 
fibrils. (a) Top: proton-decoupled 19F NMR spectrum of FSB bound to unoriented 
fibrils (in a non-spinning MAS rotor).  The best fitting powder line shape obtained by 
non-linear least squares analysis (red). Middle: Proton-coupled spectrum overlaid 
with a simulated line shape (red) corresponding to the principal values in Table 1 and 
the 1H-19F coupling constants and geometry for the 4-spin system of FSB. The 
simulation parameters were not optimised further. Bottom: proton-coupled spectrum 
of FSB bound to aligned fibrils. The line of best fit corresponds to the angles shown, 
which define the 19F CSA tensor orientation relative to the vector representing the 
fibril axis. (b) Orientation of FSB relative to the fibril axis determined experimentally 
(left) and by docking simulation (representative model). (c) Cross-sectional view of 
3Q fibril model (PDB 2LMP) showing FSB (blue) in the 10 lowest energy sites.   
bonded E-strands. The lowest-energy docking simulations of FSB with a model of 
three-fold symmetric AE40 fibrils (PDB 2LMP) concur with this orientation (Figure 
4b). A similar orientation has been proposed for thioflavin T, with the ligand binding 
along surface side-chain grooves running parallel to the fibril axis.13  FSB must 
occupy two longitudinal sites in order to account for the measured AE40:FSB 
stoichiometry of 2:1. The 8 lowest-energy docking models suggest a primary binding 
site at the innermost face of the C-terminal E-sheet, close to Ile, Val and Leu 
residues identified by REDOR NMR (Figures 4c and S9) and which form a 
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hydrophobic ladder to stabilise the ligand.  Several lower-energy models (e.g. 9 and 
10 in Figure 3c) may represent the secondary site.  
In summary, we demonstrate a direct NMR method for detecting the 
orientation of ligand molecules when bound to the surface of amyloid fibrils. 
Transferred Overhauser enhancements and residual dipolar couplings in solution 
have also been applied in this context,23-24 but these are  less suitable when ligands 
are bound tightly to insoluble fibrils. Our approach is applicable to other diagnostic 
amyloid-binding molecules such as PET ligands25 and can provide new insights into 
the binding properties of physiological ligands such as glycosaminoglycans, which 
bind tightly to amyloid. With appropriate isotope labelling of molecules with no 
intrinsic reporter nucleus, this method combined with other MAS SSNMR 
measurements,17 can provide much more detailed atomic models with which to guide 
the design of molecules targeting specific amyloid types. 
$FNQRZOHGJHPHQWV :H WKDQN 6 /LQVH DQG ' :DOVK IRU WKH JLIW RI WKH $ȕ
H[SUHVVLRQFORQH)XQGLQJZDVSURYLGHGE\%%65&8.*UDQWV%%.;DQG
%%.$GGLWLRQDOIXQGLQJZDVSURYLGHGE\%ULWLVK+HDUW)RXQGDWLRQ3URMHFW
*UDQWPG/16/18/32070. :HDFNQRZOHGJHVXSSRUWIURP&&3-1&IXQGHGE\(365&
(30DQGWKH8.&3FRQVRUWLXPIXQGHGE\(365&(33:H
DUH JUDWHIXO WR WKH 8. 0DWHULDOV DQG 0ROHFXODU 0RGHOOLQJ +XE IRU FRPSXWDWLRQDO
UHVRXUFHVZKLFKLVSDUWLDOO\IXQGHGE\(365&(33 
6XSSRUWLQJ,QIRUPDWLRQ 
$OO H[SHULPHQWDO PHWKRGV WDEOHV RI GDWD VXSSOHPHQWDU\ ILJXUHV DQG DGGLWLRQDO
UHIHUHQFHV  
12 
 
References 
1. Knowles, T. P. J.; Vendruscolo, M.; Dobson, C. M., The amyloid state and its 
association with protein misfolding diseases. Nature Reviews Molecular Cell Biology 
2014, 15 (6), 384-396. 
2. Selkoe, D. J.; Hardy, J., The amyloid hypothesis of Alzheimer's disease at 
25years. EMBO Mol. Med. 2016, 8 (6), 595-608. 
3. Meier, B. H.; Riek, R.; Bockmann, A., Emerging Structural Understanding of 
Amyloid Fibrils by Solid-State NMR. Trends Biochem. Sci. 2017, 42 (10), 777-787. 
4. Petkova, A. T.; Ishii, Y.; Balbach, J. J.; Antzutkin, O. N.; Leapman, R. D.; 
Delaglio, F.; Tycko, R., A structural model for Alzheimer's beta-amyloid fibrils based 
on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. U. S. A. 
2002, 99 (26), 16742-16747. 
5. Walti, M. A.; Ravotti, F.; Arai, H.; Glabe, C. G.; Wall, J. S.; Bockmann, A.; 
Guntert, P.; Meier, B. H.; Riek, R., Atomic-resolution structure of a disease-relevant 
A beta(1-42) amyloid fibril. Proc. Natl. Acad. Sci. U. S. A. 2016, 113 (34), E4976-
E4984. 
6. Schutz, A. K.; Vagt, T.; Huber, M.; Ovchinnikova, O. Y.; Cadalbert, R.; Wall, 
J.; Guntert, P.; Bockmann, A.; Glockshuber, R.; Meier, B. H., Atomic-Resolution 
Three-Dimensional Structure of Amyloid beta Fibrils Bearing the Osaka Mutation. 
Angewandte Chemie-International Edition 2015, 54 (1), 331-335. 
7. Colvin, M. T.; Silvers, R.; Frohm, B.; Su, Y. C.; Linse, S.; Griffin, R. G., High 
Resolution Structural Characterization of A beta(42) Amyloid Fibrils by Magic Angle 
Spinning NMR. J. Am. Chem. Soc. 2015, 137 (23), 7509-7518. 
8. Colvin, M. T.; Silvers, R.; Ni, Q. Z.; Can, T. V.; Sergeyev, I.; Rosay, M.; 
Donovan, K. J.; Michael, B.; Wall, J.; Linse, S.; Griffin, R. G., Atomic Resolution 
Structure of Monomorphic A beta(42) Amyloid Fibrils. J. Am. Chem. Soc. 2016, 138 
(30), 9663-9674. 
9. Gremer, L.; Scholzel, D.; Schenk, C.; Reinartz, E.; Labahn, J.; Ravelli, R. B. 
G.; Tusche, M.; Lopez-Iglesias, C.; Hoyer, W.; Heise, H.; Willbold, D.; Schroder, G. 
F., Fibril structure of amyloid-beta(1-42) by cryo-electron microscopy. Science 2017, 
358 (6359), 116-+. 
10. Fitzpatrick, A. W. P.; Debelouchina, G. T.; Bayro, M. J.; Clare, D. K.; Caporini, 
M. A.; Bajaj, V. S.; Jaroniec, C. P.; Wang, L. C.; Ladizhansky, V.; Muller, S. A.; 
MacPhee, C. E.; Waudby, C. A.; Mott, H. R.; De Simone, A.; Knowles, T. P. J.; 
Saibil, H. R.; Vendruscolo, M.; Orlova, E. V.; Griffin, R. G.; Dobson, C. M., Atomic 
structure and hierarchical assembly of a cross-beta amyloid fibril. Proc. Natl. Acad. 
Sci. U. S. A. 2013, 110 (14), 5468-5473. 
11. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, 
R.; Eisenberg, D., Structure of the cross-beta spine of amyloid-like fibrils. Nature 
2005, 435 (7043), 773-778. 
12. Quittot, N.; Sebastiao, M.; Bourgault, S., Modulation of amyloid assembly by 
glycosaminoglycans: from mechanism to biological significance. Biochem. Cell Biol. 
2017, 95 (3), 329-337. 
13. Biancalana, M.; Koide, S., Molecular mechanism of Thioflavin-T binding to 
amyloid fibrils. Biochimica Et Biophysica Acta-Proteins and Proteomics 2010, 1804 
(7), 1405-1412. 
14. Stewart, K. L.; Hughes, E.; Yates, E. A.; Akien, G. R.; Huang, T. Y.; Lima, M. 
A.; Rudd, T. R.; Guerrini, M.; Hung, S. C.; Radford, S. E.; Middleton, D. A., Atomic 
Details of the Interactions of Glycosaminoglycans with Amyloid-beta Fibrils. J. Am. 
Chem. Soc. 2016, 138 (27), 8328-8331. 
13 
 
15. Madine, J.; Pandya, M. J.; Hicks, M. R.; Rodger, A.; Yates, E. A.; Radford, S. 
E.; Middleton, D. A., Site-specific identification of an A-beta fibril-heparin interaction 
site by using solid-state NMR spectroscopy. Angew. Chemie. Int. Ed. 2012, 51 (52), 
13140-13143. 
16. Schutz, A. K.; Soragni, A.; Hornemann, S.; Aguzzi, A.; Ernst, M.; Bockmann, 
A.; Meier, B. H., The Amyloid-Congo Red Interface at Atomic Resolution. 
Angewandte Chemie-International Edition 2011, 50 (26), 5956-5960. 
17. Herrmann, U. S.; Schutz, A. K.; Shirani, H.; Huang, D. Z.; Saban, D.; 
Nuvolone, M.; Li, B.; Ballmer, B.; Aslund, A. K. O.; Mason, J. J.; Rushing, E.; Budka, 
H.; Nystrom, S.; Hammarstrom, P.; Bockmann, A.; Caflisch, A.; Meier, B. H.; Nilsson, 
K. P. R.; Hornemann, S.; Aguzzi, A., Structure-based drug design identifies 
polythiophenes as antiprion compounds. Sci. Transl. Med. 2015, 7 (299), 17. 
18. Petkova, A. T.; Leapman, R. D.; Guo, Z. H.; Yau, W. M.; Mattson, M. P.; 
Tycko, R., Self-propagating, molecular-level polymorphism in Alzheimer's beta-
amyloid fibrils. Science 2005, 307 (5707), 262-265. 
19. Stewart, K. L.; Hughes, E.; Yates, E. A.; Middleton, D. A.; Radford, S. E., 
Molecular Origins of the Compatibility between Glycosaminoglycans and A beta 40 
Amyloid Fibrils. J. Mol. Biol. 2017, 429 (16), 2449-2462. 
20. Oyler, N. A.; Tycko, R., Absolute structural constraints on amyloid fibrils from 
solid-state NMR spectroscopy of partially oriented samples. J. Am. Chem. Soc. 
2004, 126 (14), 4478-4479. 
21. Sato, K.; Higuchi, M.; Iwata, N.; Saido, T. C.; Sasamoto, K., Fluoro-substituted 
and C-13-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Eur. 
J. Med. Chem. 2004, 39 (7), 573-578. 
22. Velasco, A.; Fraser, G.; Delobel, P.; Ghetti, B.; Lavenir, I.; Goedert, M., 
Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB 
(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzen e. FEBS 
Lett. 2008, 582 (6), 901-906. 
23. Chen, Z. J.; Krause, G.; Reif, B., Structure and orientation of peptide inhibitors 
bound to beta-amyloid fibrils. J. Mol. Biol. 2005, 354 (4), 760-776. 
24. Ivancic, V. A.; Ekanayake, O.; Lazo, N. D., Binding Modes of ThioflavinT on 
the Surface of Amyloid Fibrils Studied by NMR. Chemphyschem 2016, 17 (16), 
2461-2464. 
25. Sabri, O.; Sabbagh, M. N.; Seibyl, J.; Barthel, H.; Akatsu, H.; Ouchi, Y.; 
Senda, K.; Murayama, S.; Ishii, K.; Takao, M.; Beach, T. G.; Rowe, C. C.; Leverenz, 
J. B.; Ghetti, B.; Ironside, J. W.; Catafau, A. M.; Stephens, A. W.; Mueller, A.; Koglin, 
N.; Hoffmann, A.; Roth, K.; Reininger, C.; Schulz-Schaeffer, W. J.; Florbetaben 
Phase 3 Study, G., Florbetaben PET imaging to detect amyloid beta plaques in 
Alzheimer's disease: Phase 3 study. Alzheimers & Dementia 2015, 11 (8), 964-974. 
 
 
